Latest publications
Epigenetic activity of peroxisome proliferator-activated receptor gamma agonists increases the anticancer effect of histone deacetylase inhibitors on multiple myeloma cells.
- Tumor Immunotherapy and Microenvironment
- Translational Radiomics
- Laboratory of Oncolytic-Virus-Immuno-Therapeutics
2015 Jun. PLoS One.10(6):e0130339.
Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450.
- Tumor Immunotherapy and Microenvironment
2015 Jun. Cell Death Dis.6:e1782.
Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.
- Tumor Immunotherapy and Microenvironment
2015 Apr. Oncogene.34(17):2261-71. Epub 2014 Jun 16.
The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing.
- Tumor Immunotherapy and Microenvironment
2015 Feb. Autophagy. [Epub ahead of print].
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
- Tumor Immunotherapy and Microenvironment
2014 Dec. N Engl J Med.371(23):2167-77.
ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy.
- Tumor Immunotherapy and Microenvironment
2014 Dec. Cancer Res.74(23):6820-32. Epub 2014 Oct 8.
Hypoxia: A key feature of the tumor microenvironment triggers several mechanisms of evasion from natural killer and cytotoxic T lymphocytes surveillance.
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
- Cytoskeleton and Cancer Progression
2014 Nov. J Imm Res.1(2):7.
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies.
- Tumor Immunotherapy and Microenvironment
2014 Nov. Ann Oncol.25(11):2147-55. Epub 2014 Aug 27.
Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity.
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
2014 Nov. Biochem Pharmacol.92(1):31-42. Epub 2014 Jul 17.
Hypoxia-induced autophagy in tumor cells: a key target for improving cancer immunotherapy.
- Tumor Stroma Interactions
- Tumor Immunotherapy and Microenvironment
2014 Sep. Cancer Cell Microenviron.1(4):e213.
[Editorial].
- Tumor Immunotherapy and Microenvironment
2014 Aug. Bull Soc Sci Med Grand Duche Luxemb.(2):7-8.
BAG6/BAT3 modulates autophagy by affecting EP300/p300 intracellular localization.
- Tumor Immunotherapy and Microenvironment
2014 Jul. Autophagy.10(7):1341-1342. Epub 2014 May 15.
Tumor plasticity interferes with anti-tumor immunity.
- Tumor Immunotherapy and Microenvironment
2014 Jun. Crit Rev Immunol.34(2):91-102.
PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
- Tumor Immunotherapy and Microenvironment
2014 May. J Exp Med.211(5):781-90. Epub 2014 Apr 28.
Bronchial airway gene expression in smokers with lung or head and neck cancer.
- NORLUX Neuro-Oncology Laboratory
- Platform LUXGEN - Micro-Array
- Tumor Immunotherapy and Microenvironment
2014 Apr. Cancer Med.3(2):322-36. Epub 2014 Feb 4.
BAT3 modulates p300-dependent acetylation of p53 and autophagy-related protein 7 (ATG7) during autophagy.
- Tumor Immunotherapy and Microenvironment
2014 Mar. Proc Natl Acad Sci U S A.111(11):4115-20. Epub 2014 Mar 3.
Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis.
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
2014 Jan. Autophagy.10(1):173-5. Epub 2013 Nov 15.
The critical role of the tumor microenvironment in shaping natural killer cell-mediated anti-tumor immunity.
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
2013 Dec. Front Immunol.4:490.
Study of the involvement of autophagy in the acquisition of tumor resistance to Natural Killer-mediated lysis. (Doctoral thesis)
- Tumor Immunotherapy and Microenvironment
2013 Nov. Paris: Université Paris-Sud, 2013. 132 p.
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.
- Tumor Immunotherapy and Microenvironment
- NORLUX Neuro-Oncology Laboratory
2013 Oct. Proc Natl Acad Sci U S A.110(43):17450-5. Epub 2013 Oct 7.